EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate.
about
EGFR ligands exhibit functional differences in models of paracrine and autocrine signalingAt the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of boneReversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system.Cbl controls EGFR fate by regulating early endosome fusion.β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.EGFR signaling in breast cancer: bad to the bone.The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activationOncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancerMycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair traffickingInsulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform AMultiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivoIntegrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair.Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancerEssential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptorFunctional selectivity of EGF family peptide growth factors: implications for cancer.Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptorEffects of membrane trafficking on signaling by receptor tyrosine kinases.ADAM17 substrate release in proximal tubule drives kidney fibrosisReconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression.Exocrine Gland Morphogenesis: Insights into the Role of Amphiregulin from Development to Disease.Where EGF receptors transmit their signals.EGF-Amphiregulin Interplay in Airway Stem/Progenitor Cells Links the Pathogenesis of Smoking-Induced Lesions in the Human Airway Epithelium.Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.Identifying Determinants of EGFR-Targeted Therapeutic Biochemical Efficacy Using Computational Modeling.Receptor Tyrosine Kinase Ubiquitination and De-Ubiquitination in Signal Transduction and Receptor Trafficking.An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.Production of amphiregulin and recovery from influenza is greater in males than females.
P2860
Q26864769-339D87FC-62BC-4BBB-AF63-3B295FC916C4Q26866067-DEE8BE0F-AA9A-433B-B125-77E1AECA5E26Q27438184-C1352132-EF61-4703-9AAB-5D0CA6B5C09DQ30492938-7C90D296-357C-438D-9A82-6B33394511D4Q33680497-FA151188-1E45-4AC3-9D6B-5C184C6A6B7DQ34249179-844BEA26-9F32-4C49-B3F7-B577A6AACEDAQ34348232-629BF38E-8D94-4ADC-9B90-0A8387175CF0Q34979150-FF458B41-71FF-4D4D-81B6-675A7C473669Q35007438-59F1DDFB-C141-47DE-B82B-779B065A9A60Q35034264-55E61469-7490-4930-9E27-D4B20ECFA2AFQ35879542-2CD97263-2671-4BDA-A6C7-CCFF6794016AQ35946392-B18C5BFF-B559-475C-B22E-5FEC8DE3C537Q36283930-8C7A1372-F775-4DBE-91D2-24C4BDA2207BQ36687542-D846AC16-CBE4-470B-A891-0C64CE7346CCQ37089778-4925A6CE-CCC7-40F6-A0FC-917160AFBB07Q37105016-97907A36-5C5E-4E15-A79D-3C17834F286AQ37149729-70F62D6D-75E2-4C88-9FF1-E65E23A5EEC0Q37151134-63A21B70-9F25-4A2C-9869-3572848EBDEFQ37258713-9B754300-99BC-46E4-B265-2502756F65BBQ37262336-E477FCA2-AE04-4A9A-BE67-64A264676F8DQ37441564-A2DD45DC-668E-47C1-9311-39CDF769101AQ37650953-9A5FB4CE-C04E-48F7-B50B-D92F2BDA0F5CQ37698606-74B143DB-4B2E-44C7-A5F3-909BA0F19794Q38199643-76DCCDDF-410A-4A4D-ADC5-F25FA4CC41E5Q38952915-00DD2169-7154-4B03-964C-6838F91B1AD3Q39358786-C3F9DC99-FCC2-408A-B3CE-7BF81D1C3ED1Q41904109-F513F252-0390-4546-BDFE-2C8550055B4AQ41904224-C66ABE3A-29FB-4642-96D7-BE8644AF6AD4Q42278129-FC20C73D-5AC6-472E-8D26-E1FB025E746AQ42418384-363E0A40-E530-47BF-BD18-EF9FD67F439AQ52654047-AFCBA1D8-21C5-4BC1-A775-297784065E0BQ53251841-5690B887-D95B-4689-9321-325228403E05Q55715145-84DDDE7A-CEAD-4416-98BF-CD8435EC2B31
P2860
EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
EGF and amphiregulin different ...... dosomes and EGF receptor fate.
@ast
EGF and amphiregulin different ...... dosomes and EGF receptor fate.
@en
type
label
EGF and amphiregulin different ...... dosomes and EGF receptor fate.
@ast
EGF and amphiregulin different ...... dosomes and EGF receptor fate.
@en
prefLabel
EGF and amphiregulin different ...... dosomes and EGF receptor fate.
@ast
EGF and amphiregulin different ...... dosomes and EGF receptor fate.
@en
P2093
P2860
P356
P1433
P1476
EGF and amphiregulin different ...... dosomes and EGF receptor fate.
@en
P2093
Kathryn A Stern
Nancy L Lill
Trenton L Place
P2860
P304
P356
10.1042/BJ20071505
P407
P577
2008-03-01T00:00:00Z